
Shares of chemicals maker Chemours CC.N up 3.1% at $17.35 premarket
Company posts smaller Q4 loss of $8 million compared to $18 million a year ago
Co says it has fully addressed all four material weaknesses in internal control previously identified in the 2023 Form 10-K
CC expects consolidated net sales to be flat to slightly down sequentially in Q1
YTD shares down 0.41% as of last close